TerminatedNCT03948464
Slow-Release Oral Morphine for the Treatment of Addiction
Medication studyAges 19–65Canada
Understand this study
Who could participate?
Listed age limits: 19 years to 65 years.
- Listed locations
- VancouverSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: December 6, 2019
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 27
- Sponsor
- M. Eugenia Socias
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Canada
- Age range
- From 19 Years to 65 Years
- Official registry ID
- NCT03948464
- Official title
Show the full official title
Repurposing Slow-Release Oral Morphine as a New Oral Alternative for the Treatment of Opioid Use Disorder
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Vancouver
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is M. Eugenia Socias.
Does this study involve medication?
Yes. The study involves medication, including Slow release oral morphine (SROM) and Methadone.
Who can participate?
Listed age limits: 19 years to 65 years.
Is this study still recruiting?
The registry lists this study as terminated.
